Clinical Evaluation of the Improvement in Bioavailability of Four Magnesium-based Products in 40 Human Volunteers After an Oral Intake by Assessing Magnesium Absorption Kinetics in Plasma for 8 Hours
Dietary supplementation with Microencapsulated Magnesium
+ Dietary supplementation with Magnesium Oxide
+ Dietary supplementation with Magnesium Citrate
Prevention Study
Summary
Study start date: January 28, 2024
Actual date on which the first participant was enrolled.This study aims to understand how well the body absorbs different forms of magnesium when taken as supplements. Magnesium is a vital nutrient needed for many body functions, including the creation of DNA and energy production. Many people do not get enough magnesium in their diet, so this research could help determine which magnesium supplements are most effective in improving magnesium levels in the body. The study involves 40 healthy volunteers aged between 20 and 55 years who will help researchers compare four types of magnesium supplements: Microencapsulated Magnesium, Magnesium Oxide, Magnesium Citrate, and Magnesium Bisglycinate. Participants will follow a special low-magnesium diet for a week before starting the test. On the test day, after fasting for 8 hours, a small blood sample will be taken from their finger, and they will then take one of the magnesium supplements orally. Blood samples will be collected at several intervals over the next 8 hours to measure the magnesium in their blood. Each participant will repeat this process for each of the four magnesium products over four weeks. The study ensures that meals and water intake are controlled to maintain consistent conditions. Blood testing is done in a non-invasive manner, and the results will help determine which supplement is most readily absorbed by the body.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.40 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Prevention Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 20 to 55 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.4 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalGroup II
ExperimentalGroup III
ExperimentalGroup IV
ExperimentalStudy Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location